Medable is taking its digital clinical trial platform to new heights: the Google Cloud Marketplace. Through the collaboration, Google Cloud’s infrastructure and AI features will be integrated into ...
The pandemic significantly changed how we do medical research, and now companies are trying to figure out what trends will stay and which ones will go. One that 4G Clinical is hoping will survive the ...
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical TM solution, a software-as-a-service (SaaS), end-to-end clinical data ...
Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...
In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...
EQT is acquiring a majority stake in CluePoints, a provider of AI software for data interrogation and analytics in clinical trials. A focus on safety, efficacy, costs, efficiency, increased complexity ...
Choosing the right EDC (electronic data capture) platform is critical for sponsors, CROs, and clinical operations teams ...
eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More. Phase Forward, a startup provider of data management ...
Two software companies that track documents and data for clinical trials have forged a partnership to cut the amount of time it takes life science firms to submit applications for approval from the ...
Teckro, a Limerick, Ireland-based maker of clinical trial software, has raised $25 million in Series C funding, bringing the company’s total backing to $43 million. TechCrunch, Reuters and others ...
McGill University researchers have developed and are licensing a digital tool to help safely reduce patients' use of medications that may be unnecessary or even harmful to them. "Sometimes we blame ...